Kailera Therapeutics KLRA
NASDAQ KLRA
$13.27 +0.06 (+0.45%)
At close: Nov 13, 2026 · 4:00 PM EST

Kailera Therapeutics (KLRA) Other non-cash items (2025 - 2026)

Updated

Kailera Therapeutics' Other non-cash items came in at -$270,000 for Q3 2026, compared with -$1.88 million a year earlier.

Analysis

Kailera Therapeutics (KLRA) Other non-cash items (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Kailera Therapeutics reported Other non-cash items of -$511,000; for FY2025, it was -$1.4 million.

  • Going back by year, Other non-cash items was -$3.4 million in FY2024.
  • The five-year range for quarterly Other non-cash items is -$1.88 million (Q3 2025) to $806,000 (Q1 2025).
  • Business Quant data shows KLRA's Other non-cash items at -$264,000 (Q2 2026), -$312,000 (Q1 2026) and $335,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Kailera Therapeutics 1.72 Bn -1.16 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -270,000.00
Jun 30, 2026 -264,000.00
Mar 31, 2026 -312,000.00
Dec 31, 2025 335,000.00
Sep 30, 2025 -1.88 Mn
Jun 30, 2025 -665,000.00
Mar 31, 2025 806,000.00
API Access

Kailera Therapeutics Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=KLRA&period=max&api_key=YOUR_API_KEY